Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity of EQ001 in Subjects With aGVHD [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports a completed Phase 1/2 study evaluating EQ001 in patients with acute graft-versus-host disease, including safety, tolerability…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• EQ001

Snippet

Sponsor: Equillium | Conditions: Acute-graft-versus-host Disease, aGVHD | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-04-18